How should we analyse FDG PET studies for monitoring tumour response? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-06-09

AUTHORS

Adriaan A. Lammertsma, Corneline J. Hoekstra, Giuseppe Giaccone, Otto S. Hoekstra

ABSTRACT

FDG PET is a promising technique for monitoring tumour response early during anticancer therapy. Progress, however, has been limited owing to the multitude of methods currently in use. Here, the most promising techniques for multi-centre trials are discussed briefly, with emphasis on the need for standardisation. In addition, an approach is presented for response monitoring studies using newly developed drugs. This approach makes use of a large database of response monitoring studies, which defines the relationship between simplified clinical methods and full quantitative analysis for classic cytotoxic drugs. For a new drug, first a pilot study is performed to assess whether it affects this relationship. Based on this pilot, it is decided whether or not a simplified clinical method can be used in further studies. More... »

PAGES

16-21

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-006-0131-5

DOI

http://dx.doi.org/10.1007/s00259-006-0131-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021173498

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16763817


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine and PET Research, VU University Medical Centre, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Nuclear Medicine and PET Research, VU University Medical Centre, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lammertsma", 
        "givenName": "Adriaan A.", 
        "id": "sg:person.01352511753.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352511753.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Jeroen Bosch Hospital, \u2018s-Hertogenbosch, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.413508.b", 
          "name": [
            "Department of Nuclear Medicine, Jeroen Bosch Hospital, \u2018s-Hertogenbosch, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoekstra", 
        "givenName": "Corneline J.", 
        "id": "sg:person.0626764200.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626764200.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, VU University Medical Centre, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, VU University Medical Centre, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giaccone", 
        "givenName": "Giuseppe", 
        "id": "sg:person.01304747074.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304747074.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine and PET Research, VU University Medical Centre, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Nuclear Medicine and PET Research, VU University Medical Centre, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoekstra", 
        "givenName": "Otto S.", 
        "id": "sg:person.0621551653.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621551653.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-004-1566-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049135908", 
          "https://doi.org/10.1007/s00259-004-1566-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002590050570", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005067118", 
          "https://doi.org/10.1007/s002590050570"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002590050484", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027047980", 
          "https://doi.org/10.1007/s002590050484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-003-1127-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040970177", 
          "https://doi.org/10.1007/s00259-003-1127-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-06-09", 
    "datePublishedReg": "2006-06-09", 
    "description": "FDG PET is a promising technique for monitoring tumour response early during anticancer therapy. Progress, however, has been limited owing to the multitude of methods currently in use. Here, the most promising techniques for multi-centre trials are discussed briefly, with emphasis on the need for standardisation. In addition, an approach is presented for response monitoring studies using newly developed drugs. This approach makes use of a large database of response monitoring studies, which defines the relationship between simplified clinical methods and full quantitative analysis for classic cytotoxic drugs. For a new drug, first a pilot study is performed to assess whether it affects this relationship. Based on this pilot, it is decided whether or not a simplified clinical method can be used in further studies.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-006-0131-5", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "keywords": [
      "tumor response", 
      "clinical methods", 
      "classic cytotoxic drugs", 
      "multi-center trial", 
      "FDG-PET studies", 
      "FDG-PET", 
      "cytotoxic drugs", 
      "PET studies", 
      "pilot study", 
      "new drugs", 
      "anticancer therapy", 
      "drugs", 
      "Further studies", 
      "response", 
      "therapy", 
      "study", 
      "trials", 
      "monitoring studies", 
      "PET", 
      "use", 
      "database", 
      "relationship", 
      "quantitative analysis", 
      "pilot", 
      "promising technique", 
      "need", 
      "standardisation", 
      "addition", 
      "method", 
      "technique", 
      "multitude", 
      "large database", 
      "analysis", 
      "multitude of methods", 
      "progress", 
      "emphasis", 
      "approach", 
      "full quantitative analysis"
    ], 
    "name": "How should we analyse FDG PET studies for monitoring tumour response?", 
    "pagination": "16-21", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021173498"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-006-0131-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16763817"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-006-0131-5", 
      "https://app.dimensions.ai/details/publication/pub.1021173498"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_421.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-006-0131-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-006-0131-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-006-0131-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-006-0131-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-006-0131-5'


 

This table displays all metadata directly associated to this object as RDF triples.

161 TRIPLES      21 PREDICATES      72 URIs      60 LITERALS      12 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-006-0131-5 schema:about N56eb721496d84875a69a55ea7cb5913c
2 N6d4396d067a4446a959955387ca4b7a1
3 N9b1364d9900d40fb8a5ec7e911136e19
4 Nb475d0e0e85d4bdeae91249072ebc7b1
5 Nb7341e5914274ae8b75a9d95cad5be2f
6 anzsrc-for:11
7 anzsrc-for:1103
8 schema:author Ndf5d3ca5029e48d798ae9ec5848d3d4b
9 schema:citation sg:pub.10.1007/s00259-003-1127-z
10 sg:pub.10.1007/s00259-004-1566-1
11 sg:pub.10.1007/s002590050484
12 sg:pub.10.1007/s002590050570
13 schema:datePublished 2006-06-09
14 schema:datePublishedReg 2006-06-09
15 schema:description FDG PET is a promising technique for monitoring tumour response early during anticancer therapy. Progress, however, has been limited owing to the multitude of methods currently in use. Here, the most promising techniques for multi-centre trials are discussed briefly, with emphasis on the need for standardisation. In addition, an approach is presented for response monitoring studies using newly developed drugs. This approach makes use of a large database of response monitoring studies, which defines the relationship between simplified clinical methods and full quantitative analysis for classic cytotoxic drugs. For a new drug, first a pilot study is performed to assess whether it affects this relationship. Based on this pilot, it is decided whether or not a simplified clinical method can be used in further studies.
16 schema:genre article
17 schema:isAccessibleForFree false
18 schema:isPartOf N36057983f0554a628c09873da107e8f9
19 N36f5bb3363314f10a7006d44d7043eaa
20 sg:journal.1297401
21 schema:keywords FDG-PET
22 FDG-PET studies
23 Further studies
24 PET
25 PET studies
26 addition
27 analysis
28 anticancer therapy
29 approach
30 classic cytotoxic drugs
31 clinical methods
32 cytotoxic drugs
33 database
34 drugs
35 emphasis
36 full quantitative analysis
37 large database
38 method
39 monitoring studies
40 multi-center trial
41 multitude
42 multitude of methods
43 need
44 new drugs
45 pilot
46 pilot study
47 progress
48 promising technique
49 quantitative analysis
50 relationship
51 response
52 standardisation
53 study
54 technique
55 therapy
56 trials
57 tumor response
58 use
59 schema:name How should we analyse FDG PET studies for monitoring tumour response?
60 schema:pagination 16-21
61 schema:productId N3813a9cb90e34473b474bf943e612d08
62 N39a43634b79b4672b6f487d8233d07d6
63 N796fe39a9e5c4a80b02a08ef4573cd2b
64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021173498
65 https://doi.org/10.1007/s00259-006-0131-5
66 schema:sdDatePublished 2022-12-01T06:25
67 schema:sdLicense https://scigraph.springernature.com/explorer/license/
68 schema:sdPublisher N67acf8f4640541af8725e8986d6153af
69 schema:url https://doi.org/10.1007/s00259-006-0131-5
70 sgo:license sg:explorer/license/
71 sgo:sdDataset articles
72 rdf:type schema:ScholarlyArticle
73 N36057983f0554a628c09873da107e8f9 schema:volumeNumber 33
74 rdf:type schema:PublicationVolume
75 N36f5bb3363314f10a7006d44d7043eaa schema:issueNumber Suppl 1
76 rdf:type schema:PublicationIssue
77 N3813a9cb90e34473b474bf943e612d08 schema:name doi
78 schema:value 10.1007/s00259-006-0131-5
79 rdf:type schema:PropertyValue
80 N39a43634b79b4672b6f487d8233d07d6 schema:name dimensions_id
81 schema:value pub.1021173498
82 rdf:type schema:PropertyValue
83 N56eb721496d84875a69a55ea7cb5913c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Radiopharmaceuticals
85 rdf:type schema:DefinedTerm
86 N67acf8f4640541af8725e8986d6153af schema:name Springer Nature - SN SciGraph project
87 rdf:type schema:Organization
88 N6d4396d067a4446a959955387ca4b7a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Neoplasms
90 rdf:type schema:DefinedTerm
91 N74b716d5a5a54292a6ac97a066744a7b rdf:first sg:person.0621551653.25
92 rdf:rest rdf:nil
93 N796fe39a9e5c4a80b02a08ef4573cd2b schema:name pubmed_id
94 schema:value 16763817
95 rdf:type schema:PropertyValue
96 N7ccc1336a7c04e4796c47ff73ce17327 rdf:first sg:person.0626764200.40
97 rdf:rest N95acf9662c0545eabb72beb16ee70f10
98 N95acf9662c0545eabb72beb16ee70f10 rdf:first sg:person.01304747074.35
99 rdf:rest N74b716d5a5a54292a6ac97a066744a7b
100 N9b1364d9900d40fb8a5ec7e911136e19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Positron-Emission Tomography
102 rdf:type schema:DefinedTerm
103 Nb475d0e0e85d4bdeae91249072ebc7b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Fluorodeoxyglucose F18
105 rdf:type schema:DefinedTerm
106 Nb7341e5914274ae8b75a9d95cad5be2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 Ndf5d3ca5029e48d798ae9ec5848d3d4b rdf:first sg:person.01352511753.53
110 rdf:rest N7ccc1336a7c04e4796c47ff73ce17327
111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
112 schema:name Medical and Health Sciences
113 rdf:type schema:DefinedTerm
114 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
115 schema:name Clinical Sciences
116 rdf:type schema:DefinedTerm
117 sg:journal.1297401 schema:issn 1619-7070
118 1619-7089
119 schema:name European Journal of Nuclear Medicine and Molecular Imaging
120 schema:publisher Springer Nature
121 rdf:type schema:Periodical
122 sg:person.01304747074.35 schema:affiliation grid-institutes:grid.16872.3a
123 schema:familyName Giaccone
124 schema:givenName Giuseppe
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304747074.35
126 rdf:type schema:Person
127 sg:person.01352511753.53 schema:affiliation grid-institutes:grid.16872.3a
128 schema:familyName Lammertsma
129 schema:givenName Adriaan A.
130 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352511753.53
131 rdf:type schema:Person
132 sg:person.0621551653.25 schema:affiliation grid-institutes:grid.16872.3a
133 schema:familyName Hoekstra
134 schema:givenName Otto S.
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621551653.25
136 rdf:type schema:Person
137 sg:person.0626764200.40 schema:affiliation grid-institutes:grid.413508.b
138 schema:familyName Hoekstra
139 schema:givenName Corneline J.
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626764200.40
141 rdf:type schema:Person
142 sg:pub.10.1007/s00259-003-1127-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1040970177
143 https://doi.org/10.1007/s00259-003-1127-z
144 rdf:type schema:CreativeWork
145 sg:pub.10.1007/s00259-004-1566-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049135908
146 https://doi.org/10.1007/s00259-004-1566-1
147 rdf:type schema:CreativeWork
148 sg:pub.10.1007/s002590050484 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027047980
149 https://doi.org/10.1007/s002590050484
150 rdf:type schema:CreativeWork
151 sg:pub.10.1007/s002590050570 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005067118
152 https://doi.org/10.1007/s002590050570
153 rdf:type schema:CreativeWork
154 grid-institutes:grid.16872.3a schema:alternateName Department of Medical Oncology, VU University Medical Centre, Amsterdam, The Netherlands
155 Department of Nuclear Medicine and PET Research, VU University Medical Centre, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands
156 schema:name Department of Medical Oncology, VU University Medical Centre, Amsterdam, The Netherlands
157 Department of Nuclear Medicine and PET Research, VU University Medical Centre, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands
158 rdf:type schema:Organization
159 grid-institutes:grid.413508.b schema:alternateName Department of Nuclear Medicine, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands
160 schema:name Department of Nuclear Medicine, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands
161 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...